• Something wrong with this record ?

Tolerability and effectiveness of an antitrauma cream with comfrey herb extract in pediatric use with application on intact and on broken skin

A. Kucera, M. Barna, S. Holcova, O. Horacek, M. Hladiková, B. Ottillinger,

. 2018 ; 5 (4) : 135-141. [pub] 20181213

Language English Country Netherlands

Document type Journal Article

Objective: The safety of comfrey herbal cream application to broken skin is still a matter of regulatory debate. It was therefore examined in children with intact and with broken skin treated for blunt traumas and sports injuries, with the aim of collecting data for pharmacovigilance and clinical safety assessments. Methods: A total of 712 children (386 children with intact skin and 326 children with abrasions and superficial wounds) were openly treated for up to 2 weeks with 1-5 applications daily of comfrey herb cream after presenting for blunt traumas and sports accidents. The incidence rate of adverse events was calculated, next to a global assessment of treatment effects. Results: No adverse events occurred in the group of children with intact skin, and one intolerability reaction (burning and reddening) was observed after application to broken skin. The overall incidence rate of intolerability reactions per patient was calculated as 0.14% (95% CI 0.00-0.78%) and that of systemic adverse effects as 0.00% (95% CI 0.00-0.42%). Accordingly, the probability of the occurrence of local reactions and systemic adverse events is well below, which is one in 100 treated patients. The global assessment of effects corresponded to previously published experience. Conclusion: These studies confirm an excellent benefit-to-risk ratio for the application of comfrey herb cream in the treatment of blunt traumas and sports injuries in children with intact and with broken skin.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19013310
003      
CZ-PrNML
005      
20190426133940.0
007      
ta
008      
190405s2018 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpam.2018.11.002 $2 doi
035    __
$a (PubMed)30805549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kucera, Alexander $u 2nd Medical Faculty of the Charles University, V Úvalu 84, 15006 Prague 5, Czech Republic.
245    10
$a Tolerability and effectiveness of an antitrauma cream with comfrey herb extract in pediatric use with application on intact and on broken skin / $c A. Kucera, M. Barna, S. Holcova, O. Horacek, M. Hladiková, B. Ottillinger,
520    9_
$a Objective: The safety of comfrey herbal cream application to broken skin is still a matter of regulatory debate. It was therefore examined in children with intact and with broken skin treated for blunt traumas and sports injuries, with the aim of collecting data for pharmacovigilance and clinical safety assessments. Methods: A total of 712 children (386 children with intact skin and 326 children with abrasions and superficial wounds) were openly treated for up to 2 weeks with 1-5 applications daily of comfrey herb cream after presenting for blunt traumas and sports accidents. The incidence rate of adverse events was calculated, next to a global assessment of treatment effects. Results: No adverse events occurred in the group of children with intact skin, and one intolerability reaction (burning and reddening) was observed after application to broken skin. The overall incidence rate of intolerability reactions per patient was calculated as 0.14% (95% CI 0.00-0.78%) and that of systemic adverse effects as 0.00% (95% CI 0.00-0.42%). Accordingly, the probability of the occurrence of local reactions and systemic adverse events is well below, which is one in 100 treated patients. The global assessment of effects corresponded to previously published experience. Conclusion: These studies confirm an excellent benefit-to-risk ratio for the application of comfrey herb cream in the treatment of blunt traumas and sports injuries in children with intact and with broken skin.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Barna, Milos $u Ordination for Rehabilitation, Marakova 3/263, 16000 Prague 6, Czech Republic.
700    1_
$a Holcova, Simona $u Outpatient Department of Dermatovenerology, Jugoslávská 13, CZ-61300 Brno 2, Czech Republic.
700    1_
$a Horacek, Ondrej $u 2nd Medical Faculty of the Charles University, V Úvalu 84, 15006 Prague 5, Czech Republic.
700    1_
$a Hladiková, Marie $u Department of Medical Informatics, 2nd Faculty of Medicine, Charles University of Prague, V Úvalu 84, CZ-15006 Prague 5, Czech Republic.
700    1_
$a Ottillinger, Bertram $u Ottillinger Life Sciences, Foehrenstrasse 12, D-85649, Brunnthal-Hofolding, Germany.
773    0_
$w MED00198718 $t International journal of pediatrics & adolescent medicine $x 2352-6467 $g Roč. 5, č. 4 (2018), s. 135-141
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30805549 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190426134017 $b ABA008
999    __
$a ind $b bmc $g 1392620 $s 1051615
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 5 $c 4 $d 135-141 $e 20181213 $i 2352-6467 $m International journal of pediatrics & adolescent medicine $n Int J Pediatr Adolesc Med $x MED00198718
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...